Ryan Acy
Senior Vice President of Corporate Affairs
Replay available
Revolution Medicines, Inc. (RVMD) Q4 2025 Earnings Call
Revolution Medicines, Inc. (NASDAQ: RVMD) Q4 2025 earnings conference call, held 2026-02-25. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Mark Goldsmith
Chairman and Chief Executive Officer
Jack Anders
Chief Financial Officer
Dr. Steve Kelsey
President of Research and Development
Dr. Alan Sandler
Chief Development Officer
Dr. Wei Lin
Chief Medical Officer
Anthony Mancini
Chief Global Commercialization Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Revolution Medicines, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.116 Good day, and thank you for standing by. Welcome to Revolution Medicine's fourth quarter 00:00:05.116 -- 00:00:10.222 2025 earnings conference call. After the speaker's presentation, there will be 00:00:10.222 -- 00:00:15.267 a question and answer session. To ask a question during your session, you will need to 00:00:15.267 -- 00:00:20.333 press star 11 on your telephone. You will then hear an automated message advising 00:00:20.333 -- 00:00:25.559 that your hand is raised. To withdraw your question, please press star 11 again. 00:00:25.559 -- 00:00:27.000 Please 00:00:27.000 -- 00:00:30.136 be advised that today's conference is being recorded. 00:00:30.136 -- 00:00:35.165 I would now like to hand the conference over to your first speaker today, Ryan Acy, Senior 00:00:35.165 -- 00:00:39.273 Vice President of Corporate Affairs. Ryan, please go ahead. 00:00:39.273 -- 00:00:41.273 Thank 00:00:42.218 -- 00:00:46.866 you, and welcome everyone to our fourth quarter and full year 2025 earnings call. 00:00:46.866 -- 00:00:51.655 Joining me on today's call are Dr. Mark Goldsmith, our Chairman and Chief Executive Officer, 00:00:51.655 -- 00:00:54.470 and Jack Anders, our Chief Financial Officer. 00:00:54.470 -- 00:00:58.235 Dr. Steve Kelsey, our President of Research and Development, Dr. 00:00:58.235 -- 00:01:01.439 Alan Sandler, our Chief Development Officer, Dr. 00:01:01.439 -- 00:01:06.184 Wei Lin, our Chief Medical Officer, and Anthony Mancini, our Chief Global Commercialization 00:01:06.184 -- 00:01:09.929 Officer, will join us for the Q&A portion of today's call. 00:01:09.929 -- 00:01:13.473 Before we begin, I'd like to remind everyone that certain statements we make during this 00:01:13.473 -- 00:01:17.258 call will be forward-looking...